Asia Pacific Anatomic Pathology Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$7,737.8

Forecast, 2030 (US$M)

$16,653.3

CAGR, 2024 - 2030

11.6%

Report Coverage

Asia Pacific

Asia Pacific anatomic pathology market, 2018-2030 (US$M)

Related Markets

Global Anatomic Pathology Industry Outlook

North America Anatomic Pathology Market Outlook

Europe Anatomic Pathology Market Outlook

Latin America Anatomic Pathology Market Outlook

MEA Anatomic Pathology Market Outlook

Asia Pacific anatomic pathology market highlights

The Asia Pacific anatomic pathology market generated a revenue of USD 7,737.8 million in 2023.
The market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
In terms of segment, instruments was the largest revenue generating product & services in 2023.
Instruments is the most lucrative product & services segment registering the fastest growth during the forecast period.

Asia Pacific data book summary

Market revenue in 2023	USD 7,737.8 million
Market revenue in 2030	USD 16,653.3 million
Growth rate	11.6% (CAGR from 2023 to 2030)
Largest segment	Instruments
Fastest growing segment	Instruments
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Instruments
Key market players worldwide	Danaher Corp, PHC Holdings Corp, Quest Diagnostics Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Agilent Technologies Inc, Cardinal Health Inc, Sakura Finetek USA, Inc., NeoGenomics, Biogenex, Bio SB

Other key industry trends

In terms of revenue, Asia Pacific region accounted for 23.8% of the global anatomic pathology market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 16,653.3 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Anatomic Pathology Market Scope

Anatomic pathology market segmentation & scope

Product & Services

Instruments

Microtomes & Cryostat microtomes

Tissue processors

Automatic strainers

Whole Slide Imaging (WSI) Scanners

Other products

Consumables

Reagents & Antibodies

Probes & Kits

Others

Services

Application

Disease Diagnosis

Drug Discovery And Development

Others

End Use

Hospitals

Research Laboratories

Diagnostic Laboratories

Others

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

China

India

Brazil

Mexico

South Africa

Anatomic Pathology Market Companies

Name	Profile	# Employees	HQ	Website

Asia Pacific anatomic pathology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anatomic pathology market will help companies and investors design strategic landscapes.

Instruments was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific anatomic pathology market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.

With two-thirds of the world’s population, improving economies in this region as well as growing demand for testing in this region is expected to boost market growth over the forecast period.

Use of biomarkers in anatomic pathology practices in this region is different from western markets as this regional market is primarily based on lower labor costs, high population, and low-cost operations.

Reasons to subscribe to Asia Pacific anatomic pathology market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific anatomic pathology market databook

Our clientele includes a mix of anatomic pathology market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific anatomic pathology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific anatomic pathology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list